Medication-overuse headache: a widely recognized entity amidst ongoing debate

1.

Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12:575–583. https://doi.org/10.1038/nrneurol.2016.124 PubMedCrossRef

2.

Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401. https://doi.org/10.1016/S1474-4422(10)70008-9 PubMedCrossRef

3.

Boes CJ, Capobianco DJ (2005) Chronic migraine and medication-overuse headache through the ages. Cephalalgia 25:378–390. https://doi.org/10.1111/j.1468-2982.2005.00868.x PubMedCrossRef

4.

Lennox W (1934) The use of ergotamine tartrate in migraine. N Engl J Med 210:1061–1065CrossRef

5.

Silfverskiöld B (1947) Gynergen abuse in cases of migraine. Acta Psychi Search results. Acta Psychiatr Neurol 46:281–285CrossRef

6.

Graham JR (1955) Treatment of migraine. N Engl J Med 253:726–730; contd. https://doi.org/10.1056/NEJM195510272531705

7.

Lippman CW (1955) Characteristic headache resulting from prolonged use of ergot derivatives. J Nerv Ment Dis 121:270–273

8.

Friedman AP, Von Storch TJ (1955) Ergotamine tolerance in patients with migraine. J Am Med Assoc 157:881–884

9.

Peters GA, Horton BT (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 26:153–161PubMed

10.

Horton B, Peters G (1963) Clinical manifestations of excessive use of ergotamine preparations and Management of Withdrawal Effect: report of 52 cases. Headache J Head Face Pain 2:214–229. https://doi.org/10.1111/j.1526-4610.1963.hed0204214.x CrossRef

11.

Wörz R, Baar H, Draf W et al (1975) Headache and dependence on mixed analgesic preparations. MMW Munch Med Wochenschr 117:457–462PubMed

12.

Worz R (1980) Abuse and paradoxical effects of analgesic drug mixtures. Br J Clin Pharmacol 10:391S–393S. https://doi.org/10.1111/j.1365-2125.1980.tb01828.x PubMedPubMedCentralCrossRef

13.

Mathew NT, Stubits E, Nigam MP (1982) Transformation of episodic migraine into daily headache: analysis of factors. Headache J Head Face Pain 22:66–68. https://doi.org/10.1111/j.1526-4610.1982.hed2202066.x CrossRef

14.

Mathew NT, Reuveni U, Perez F (1987) Transformed or Evolutive migraine. Headache J Head Face Pain 27:102–106. https://doi.org/10.1111/j.1526-4610.1987.hed2702102.x CrossRef

15.

Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification Committee of the International Headache Society. Cephalalgia 8(Suppl 7):1–96

16.

Kaube H, May A, Pfaffenrath V (1994) Sumatriptan. BMJ 308:1573–1574PubMedPubMedCentralCrossRef

17.

Limmroth V, Kazarawa Z, Fritsche G, Diener HC (1999) Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 353:378. https://doi.org/10.1016/S0140-6736(05)74950-3 PubMedCrossRef

18.

Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011–1014. https://doi.org/10.1212/WNL.59.7.1011 PubMedCrossRef

19.

Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 34:1–7CrossRef

20.

Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160

21.

Olesen J, Bousser MG, Diener HC et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746. https://doi.org/10.1111/j.1468-2982.2006.01172.x PubMedCrossRef

22.

Headache Classification Committee of the International Headache Society (2018) Headache classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211. https://doi.org/10.1177/0333102417738202 CrossRef

23.

Manzoni G, Torelli P (2015) Chronic headaches: a clinician’s experience of ICHD3 beta. Neurol Sci 36:51–55. https://doi.org/10.1007/s10072 PubMedCrossRef

24.

Tepper S (2012) Medication-overuse headache (MOH). Contin Lifelong Learn Neurol 18:807–822. https://doi.org/10.1007/978-3-319-19911-5_19 CrossRef

25.

Scher AI, Lipton RB, Stewart WF, Bigal M (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30:321–328. https://doi.org/10.1111/j.1468-2982.2009.01913.x PubMedCrossRef

26.

Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71:1821–1828. https://doi.org/10.1212/01.wnl.0000335946.53860.1d PubMedCrossRef

27.

Katsarava Z, Schneeweiss S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788–790. https://doi.org/10.1212/01.WNL.0000113747.18760.D2 PubMedCrossRef

28.

Westergaard ML, Hansen EH, Glümer C et al (2014) Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia 34:409–425. https://doi.org/10.1177/0333102413512033 PubMedCrossRef

29.

Ayzenberg I, Katsarava Z, Sborowski A et al (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32:373–381. https://doi.org/10.1177/0333102412438977 PubMedCrossRef

30.

Park J-W, Moon H-S, Kim J-M et al (2014) Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol 10:236. https://doi.org/10.3988/jcn.2014.10.3.236 PubMedPubMedCentralCrossRef

31.

Yu S, Liu R, Zhao G et al (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52:582–591. https://doi.org/10.1111/j.1526-4610.2011.02061.x PubMedCrossRef

32.

Zebenigus M, Tekle-Haimanot R, Worku DK et al (2016) The prevalence of primary headache disorders in Ethiopia. J Headache Pain 17:110. https://doi.org/10.1186/s10194-016-0704-z PubMedPubMedCentralCrossRef

33.

Mbewe E, Zairemthiama P, Yeh H-H et al (2015) The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 16:515. https://doi.org/10.1186/s10194-015-0515-7 PubMedCrossRef

34.

Da Silva A, Costa EC, Gomes JB et al (2010) Chronic headache and comorbibities: a two-phase, population-based, cross-sectional study. Headache 50:1306–1312. https://doi.org/10.1111/j.1526-4610.2010.01620.x PubMedCrossRef

35.

Westergaard ML, Munksgaard SB, Bendtsen L, Jensen RH (2016) Medication-overuse headache: a perspective review. Ther Adv Drug Saf 7:147–158. https://doi.org/10.1177/2042098616653390 PubMedPubMedCentralCrossRef

36.

Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf 5:87–99. https://doi.org/10.1177/2042098614522683 PubMedPubMedCentralCrossRef

37.

Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990?2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800. https://doi.org/10.1016/S0140 PubMedCentralCrossRef

38.

Cheung V, Amoozegar F, Dilli E (2015) Medication overuse headache. Curr Neurol Neurosci Rep 15:509. https://doi.org/10.1007/s11910-014-0509-x PubMedCrossRef

39.

Munksgaard SB, Jensen RH (2014) Medication overuse headache. Headache 54:1251–1257. https://doi.org/10.1111/head.12408 PubMedCrossRef

40.

Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E (2011) Refractory migraine in a headache clinic population. BMC Neurol 11(1):94. https://doi.org/10.1186/1471-2377-11-94 PubMedPubMedCentralCrossRef

41.

Wang S-J, Fuh J-L, Liu C-Y et al (2000) Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 54:314–319. https://doi.org/10.1212/WNL.54.2.314 PubMedCrossRef

42.

Straube A, Pfaffenrath V, Ladwig KH et al (2010) Prevalence of chronic migraine and medication overuse headache in Germany - the German DMKG headache study. Cephalalgia 30:207–213. https://doi.org/10.1111/j.1468-2982.2009.01906.x PubMedCrossRef

43.

Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31:1015–1022. https://doi.org/10.1177/0333102411410082 PubMedCrossRef

44.

Gelfand AA, Goadsby PJ (2014) Medication overuse in children and adolescents. Curr Pain Headache Rep 18:428. https://doi.org/10.1016/j.neuron.2009.10.017.A PubMedPubMedCentralCrossRef

45.

Lipton RB, Manack A, Ricci JA et al (2011) Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 51:693–706. https://doi.org/10.1111/j.1526-4610.2011.01885.x PubMedCrossRef

46.

Wiendels NJ, van der Geest MCM, Neven MSAK et al (2005) Chronic daily headache in children and adolescents. Headache J Head Face Pain 45:678–683. https://doi.org/10.1111/j.1526-4610.2005.05137.x CrossRef

47.

Maffioletti E, Ferro F, Pucci E et al (2015) P035. Headache prevalence and disability among Italian adolescents aged 11-15 years: a population cross-sectional study. J Headache Pain 16:A148. https://doi.org/10.1186/1129-2377-16-S1-A148 PubMedPubMedCentralCrossRef

48.

Wang S-J, Fuh J-L, Lu S-R, Juang K-D (2006) Chronic daily headache in adolescents. Neurology 66:193–197. https://doi.org/10.1212/WNL.0b013e3181d2b185 PubMedCrossRef

49.

Krogh AB, Larsson B, Linde M (2015) Prevalence and disability of headache among Norwegian adolescents: a cross-sectional school-based study. Cephalalgia 35:1181–1191. https://doi.org/10.1177/0333102415573512 PubMedCrossRef

50.

Moore AJ, Shevell M (2004) Chronic daily headaches in pediatric neurology practice. J Child Neurol 19:925–929PubMedCrossRef

51.

Prencipe M, Casini AR, Ferretti C et al (2001) Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 70:377–381. https://doi.org/10.1136/jnnp.70.3.377 PubMedPubMedCentralCrossRef

52.

de Rijk P, Resseguier N, Donnet A (2017) Headache characteristics and clinical features of elderly migraine patients. Headache J Head Face Pain 58(4):525–533. https://doi.org/10.1111/head.13247 CrossRef

53.

Westergaard ML, Glumer C, Hansen EH, Jensen RH (2014) Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain 155:2005–2013. https://doi.org/10.1016/j.pain.2014.07.002 PubMedCrossRef

54.

Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703–711. https://doi.org/10.1111/j.1468-1331.2011.03612.x PubMedCrossRef

55.

Steiner TJ (2005) Lifting the burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373–377. https://doi.org/10.1007/s10194-005-0241-7 PubMedPubMedCentralCrossRef

56.

Steiner TJ, Stovner LJ, Katsarava Z et al (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15:1–11. https://doi.org/10.1186/1129-2377-15-31 CrossRef

57.

Vos T, Abajobir AA, Abate KH et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 390:1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2 CrossRef

58.

Ashina S, Lyngberg A, Jensen RH (2010) Headache characteristics and chronification of migraine and tension-type headache: a population-based study. Cephalalgia 30:943–954. https://doi.org/10.1177/0333102409357958 PubMedCrossRef

59.

Thorlund K, Sun-Edelstein C, Druyts E et al (2016) Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain 17(1):107. https://doi.org/10.1186/s10194-016-0696-8 PubMedPubMedCentralCrossRef

60.

Bigal ME, Serrano D, Buse D et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168. https://doi.org/10.1111/j.1526-4610.2008.01217.x PubMedCrossRef

61.

Paemeleire K, Bahra A, Evers S et al (2006) Medication-overuse headache in patients with cluster headache. Neurology 67:109–113. https://doi.org/10.1111/j.1468-2982.2008.01736.x PubMedCrossRef

62.

Paemeleire K, Evers S, Goadsby PJ (2008) Medication overuse headache in patients with cluster headache. Curr Pain Headache Rep 12:122–127PubMedCrossRef

63.

Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41:303–309. https://doi.org/10.1046/j.1526-4610.2001.111006303.x PubMedCrossRef

64.

Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190. https://doi.org/10.1046/j.1526-4610.2003.03041.x PubMedCrossRef

65.

Hagen K, Albretsen C, Vilming ST et al (2011) A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study. J Headache Pain 12:315–322. https://doi.org/10.1007/s10194-010-0285-1 PubMedPubMedCentralCrossRef

66.

Cevoli S, Sancisi E, Grimaldi D et al (2009) Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49:412–418. https://doi.org/10.1111/j.1526-4610.2008.01257.x PubMedCrossRef

67.

Bigal ME, Lipton RB (2007) The differential diagnosis of chronic daily headaches: an algorithm-based approach. J Headache Pain 8:263–272. https://doi.org/10.1007/s10194-007-0418-3 PubMedPubMedCentralCrossRef

68.

Baumgartner C, Wessely P, Bingöl C et al (1989) Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29:510–514. https://doi.org/10.1111/j.1526-4610.1989.hed2908510.x PubMedCrossRef

69.

Hagen K, Linde M, Steiner TJ et al (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag health studies. Pain 153:56–61. https://doi.org/10.1016/j.pain.2011.08.018 PubMedCrossRef

70.

Ashina S, Serrano D, Lipton RB et al (2012) Depression and risk of transformation of episodic to chronic migraine. J Headache Pain 13:615–624. https://doi.org/10.1007/s10194-012-0479-9 PubMedPubMedCentralCrossRef

71.

Sarchielli P, Corbelli I, Messina P et al (2016) Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Eur J Neurol 23:85–91. https://doi.org/10.1111/ene.12794 PubMedCrossRef

72.

Kristoffersen ES, Straand J, Russell MB, Lundqvist C (2016) Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study. Eur J Neurol 23:28–35. https://doi.org/10.1111/ene.12850 PubMedCrossRef

73.

Bendtsen L, Munksgaard SB, Tassorelli C et al (2014) Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 34:426–433. https://doi.org/10.1177/0333102413515338 PubMedCrossRef

74.

Lampl C, Thomas H, Tassorelli C et al (2016) Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain 17(1):59. https://doi.org/10.1186/s10194-016-0649-2 PubMedPubMedCentralCrossRef

75.

Curone M, Tullo V, Mea E et al (2011) Psychopathological profile of patients with chronic migraine and medication overuse : study and findings in 50 cases. Neurol Sci 32:177–179. https://doi.org/10.1007/s10072-011-0527-2 CrossRef

76.

Cupini LM, Murtas MD, Costa C et al (2009) Obsessive-compulsive disorder and migraine with medication-overuse headache: research submission. Headache 49:1005–1013. https://doi.org/10.1111/j.1526-4610.2009.01457.x PubMedCrossRef

77.

Radat F, Lanteri-Minet M (2010) What is the role of dependence-related behavior in medication-overuse headache? Headache 50:1597–1611. https://doi.org/10.1111/j.1526-4610.2010.01755.x PubMedCrossRef

78.

Galli F, Pozzi G, Frustaci A et al (2011) Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache 51:1212–1227. https://doi.org/10.1111/j.1526-4610.2011.01978.x PubMedCrossRef

79.

Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89. https://doi.org/10.1016/S0304-3959(03)00293-8 PubMedCrossRef

80.

Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66:545–550. https://doi.org/10.1212/01.wnl.0000197218.05284.82 PubMedCrossRef

81.

He Z, Dong L, Zhang Y et al (2015) Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur J Neurol 22:1228–1234. https://doi.org/10.1111/ene.12732 PubMedCrossRef

82.

Westergaard ML, Glümer C, Hansen EH, Jensen RH (2016) Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia 36:15–28. https://doi.org/10.1177/0333102415578430 PubMedCrossRef

83.

Hershey AD, Powers SW, Nelson TD et al (2009) Obesity in the pediatric headache population: a multicenter study. Headache J Head Face Pain 49:170–177. https://doi.org/10.1111/j.1526-4610.2008.01232.x CrossRef

84.

Pakalnis A, Kring D (2012) Chronic daily headache, medication overuse, and obesity in children and adolescents. J Child Neurol 27:577–580. https://doi.org/10.1177/0883073811420869 PubMedCrossRef

85.

Sancisi E, Cevoli S, Vignatelli L et al (2010) Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache 50:1464–1472. https://doi.org/10.1111/j.1526-4610.2010.01711.x PubMedCrossRef

86.

Srikiatkhachorn A, le Grand SM, Supornsilpchai W, Storer RJ (2014) Pathophysiology of medication overuse headache-an update. Headache J Head Face Pain 54:204–210. https://doi.org/10.1111/head.12224 CrossRef

87.

Schwedt TJ, Chong CD (2017) Medication overuse headache: pathophysiological insights from structural and functional brain MRI research. Headache J Head Face Pain 57(7):1173–1178. https://doi.org/10.1111/head.13037 CrossRef

88.

Lai T, Wang S (2018) Neuroimaging findings in patients with medication overuse headache. Curr Pain Headache Rep 22:1. https://doi.org/10.1007/s11916-018-0661-0 PubMedCrossRef

89.

Supornsilpchai W, Maneesri Le Grand S, Srikiatkhachorn A (2010) Cortical hyperexcitability and mechanism of medication-overuse headache. Cephalalgia 30:1101–1109. https://doi.org/10.1177/0333102409355600 PubMedCrossRef

90.

Green A, Gu P, De Felice M et al (2014) Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Cephalalgia 34:594–604. https://doi.org/10.1016/j.smim.2015.08.001.Control PubMedCrossRef

91.

Bongsebandhu-Phubhakdi S, Srikiatkhachorn A (2012) Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep 16:110–115. https://doi.org/10.1007/s11916-011-0234-y PubMedCrossRef

92.

Belanger S, Ma W, Chabot J-G, Quirion R (2002) Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience 115:441–453. https://doi.org/10.1016/S0306-4522(02)00452-9 PubMedCrossRef

93.

De Felice M, Ossipov MH, Wang R et al (2010) Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 133:2475–2488. https://doi.org/10.1093/brain/awq159 PubMedPubMedCentralCrossRef

94.

Okada-Ogawa A, Porreca F, Meng ID (2009) Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls (DNIC) in dura-sensitive medullary dorsal horn neurons. J Neurosci 29:15828–15835. https://doi.org/10.3174/ajnr.A1256.Functional PubMedPubMedCentralCrossRef

95.

Wanasuntronwong A, Jansri U, Srikiatkhachorn A (2017) Neural hyperactivity in the amygdala induced by chronic treatment of rats with analgesics may elucidate the mechanisms underlying psychiatric comorbidities associated with medication-overuse headache. BMC Neurosci 18:1–12. https://doi.org/10.1186/s12868-016-0326-z PubMedPubMedCentralCrossRef

96.

Srikiatkhachorn A, Tarasub N, Govitrapong P (2000) Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 40:343–350. https://doi.org/10.1046/j.1526-4610.2000.00052.x PubMedCrossRef

97.

Tohyama Y, Yamane F, Merid MF, Diksic M (2001) Effects of selective 5-HT1A receptor antagonists on regional serotonin synthesis in the rat brain: an autoradiographic study with alpha-[14C] methyl-L-tryptophan. Eur Neuropsychopharmacol 11:193–202PubMedCrossRef

98.

Dobson CF, Tohyama Y, Diksic M, Hamel E (2004) Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 24:2–11. https://doi.org/10.1111/j.1468-2982.2004.00647.x PubMedCrossRef

99.

Srikiatkhachorn A, Anthony M (1996) Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 16:423–426. https://doi.org/10.1046/j.1468-2982.1996.1606423.x PubMedCrossRef

100.

Cargnin S, Viana M, Sances G et al (2017) A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache. Cephalalgia 0:1–13. https://doi.org/10.1177/0333102417728244 CrossRef

101.

Pisanu C, Caproni S, Congiu D et al (2015) HDAC3 role in medication consumption in medication overuse headache patients: a pilot study. Hum Genomics 9:30. https://doi.org/10.1186/s40246-015-0051-1 PubMedPubMedCentralCrossRef

102.

Terrazzino S, Sances G, Balsamo F et al (2010) Role of 2 common variants of 5HT2A gene in medication overuse headache. Headache 50:1587–1596. https://doi.org/10.1111/j.1526-4610.2010.01757.x PubMedCrossRef

103.

Di Lorenzo C, Sances G, Di Lorenzo G et al (2007) The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett 424:179–184. https://doi.org/10.1016/j.neulet.2007.07.037 PubMedCrossRef

104.

Cargnin S, Viana M, Ghiotto N et al (2014) Functional polymorphisms in COMT and SLC6A4 genes influence the prognosis of patients with medication overuse headache after withdrawal therapy. Eur J Neurol 21:989–995. https://doi.org/10.1111/ene.12424 PubMedCrossRef

105.

Cevoli S, Mochi M, Scapoli C et al (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13:1009–1013. https://doi.org/10.1111/j.1468-1331.2006.01415.x PubMedCrossRef

106.

Di Lorenzo C, Di Lorenzo G, Sances G et al (2009) Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10:349–355. https://doi.org/10.1007/s10194-009-0136-0 PubMedPubMedCentralCrossRef

107.

Di Lorenzo C, Coppola G, Currà A et al (2012) Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism. Cephalalgia 32:1189–1197. https://doi.org/10.1177/0333102412461890 PubMedCrossRef

108.

Woolf CJ (2012) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152:1–31. https://doi.org/10.1016/j.pain.2010.09.030.Central CrossRef

109.

Coppola G, Curra A, Di Lorenzo C et al (2010) Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol 10:126. https://doi.org/10.1186/1471-2377-10-126 PubMedPubMedCentralCrossRef

110.

Curra A, Coppola G, Gorini M et al (2011) Drug-induced changes in cortical inhibition in medication overuse headache. Cephalalgia an Int jounal headache 31:1282–1290. https://doi.org/10.1177/0333102411415877 CrossRef

111.

Munksgaard SB, Bendtsen L, Jensen RH (2013) Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study. Cephalalgia 33:444–453. https://doi.org/10.1177/0333102412475235 PubMedCrossRef

112.

Riederer F, Marti M, Luechinger R et al (2012) Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety. World J Biol Psychiatry 13:517–525. https://doi.org/10.3109/15622975.2012.665175 PubMedCrossRef

113.

Michels L, Christidi F, Steiger VR et al (2017) Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain - a multimodal MRI study. Cephalalgia 37:764–779. https://doi.org/10.1177/0333102416652625 PubMedCrossRef

114.

Schmidt-Wilcke T, Leinisch E, Straube A et al (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65:1483–1486. https://doi.org/10.1212/01.wnl.0000183067.94400.80 PubMedCrossRef

115.

Chanraud S, Di Scala G, Dilharreguy B et al (2014) Brain functional connectivity and morphology changes in medication-overuse headache: clue for dependence-related processes? Cephalalgia 34:605–615. https://doi.org/10.1177/0333102413519514 PubMedCrossRef

116.

Ferraro S, Grazzi L, Mandelli ML et al (2012) Pain processing in medication overuse headache: a functional magnetic resonance imaging (FMRI) study. Pain Med 13:255–262. https://doi.org/10.1111/j.1526-4637.2011.01183.x PubMedCrossRef

117.

Ferraro S, Grazzi L, Muffatti R et al (2012) In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas. Headache 52:1520–1534. https://doi.org/10.1111/j.1526-4610.2012.02276.x PubMedCrossRef

118.

Torta DM, Costa T, Luda E et al (2016) Nucleus accumbens functional connectivity discriminates medication-overuse headache. NeuroImage Clin 11:686–693. https://doi.org/10.1016/j.nicl.2016.05.007 PubMedPubMedCentralCrossRef

119.

Fumal A, Laureys S, Di Clemente L et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543–550. https://doi.org/10.1093/brain/awh691 PubMedCrossRef

120.

Riederer F, Schaer M, Gantenbein AR et al (2017) Cortical alterations in medication-overuse headache. Headache 57:255–265. https://doi.org/10.1111/head.12993 PubMedCrossRef

121.

Riederer F, Gantenbein AR, Marti M et al (2013) Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex. J Neurosci 33:15343–15349. https://doi.org/10.1523/JNEUROSCI.3804-12.2013 PubMedCrossRef

122.

Rapoport AM (2008) Medication overuse headache: awareness, detection and treatment. CNS Drugs 22:995–1004. https://doi.org/10.2165/0023210-200822120-00003%5Cr22123 PubMedCrossRef

123.

Rossi P, Di Lorenzo C, Faroni J et al (2006) Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26:1097–1105. https://doi.org/10.1111/j.1468-2982.2006.01175.x PubMedCrossRef

124.

Jonsson P, Linde M, Hensing G, Hedenrud T (2012) Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 13:281–290. https://doi.org/10.1007/s10194-012-0432-y PubMedPubMedCentralCrossRef

125.

Bekkelund SI, Salvesen R (2002) Patient satisfaction with a neurological specialist consultation for headache. Scand J Prim Health Care 20:157–160. https://doi.org/10.1080/028134302760234609 PubMedCrossRef

126.

Negro A, Curto M, Lionetto L et al (2017) A critical evaluation on MOH current treatments. Curr Treat Options Neurol 19:32. https://doi.org/10.1007/s11940-017-0465-2 PubMedCrossRef

127.

Jonsson P, Jakobsson A, Hensing G et al (2013) Holding on to the indispensable medication-- a grounded theory on medication use from the perspective of persons with medication overuse headache. J Headache Pain 14:43. https://doi.org/10.1186/1129 PubMedPubMedCentralCrossRef

128.

Fritsche G, Frettlöh J, Hüppe M et al (2010) Prevention of medication overuse in patients with migraine. Pain 151:404–413. https://doi.org/10.1016/j.pain.2010.07.032 PubMedCrossRef

129.

Kristoffersen ES, Straand J, Vetvik KG et al (2015) Brief intervention for medication-overuse headache in primary care. The BIMOH study:a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry 86:505–512. https://doi.org/10.1136/jnnp-2014-308548 PubMedCrossRef

130.

Mehuys E, Paemeleire K, Van Hees T et al (2012) Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol 19:1093–1099. https://doi.org/10.1111/j.1468-1331.2012.03681.x PubMedCrossRef

131.

Hedenrud T, Babic N, Jonsson P (2014) Medication overuse headache: self-perceived and actual knowledge among pharmacy staff. Headache 54:1019–1025. https://doi.org/10.1111/head.12350 PubMedCrossRef

132.

Carlsen LN, Westergaard ML, Bisgaard M et al (2017) National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia 0:033310241773689. https://doi.org/10.1177/0333102417736898 CrossRef

133.

Louter MA, Robbins MS, Terwindt GM (2017) Medication overuse headache: an ongoing debate. Neurology 89:1206–1207. https://doi.org/10.1212/WNL.0000000000004374 PubMedCrossRef

134.

Olesen J (2012) Detoxification for medication overuse headache is the primary task. Cephalalgia 32:420–422. https://doi.org/10.1177/0333102411431309 PubMedCrossRef

135.

Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66:1894–1898. https://doi.org/10.1212/01.wnl.0000217914.30994.bd PubMedCrossRef

136.

Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L (2018) Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 38:225–236. https://doi.org/10.1177/0333102417737779 PubMedCrossRef

137.

Evers S, Jensen R, European Federation of Neurological Societies (2011) Treatment of medication overuse headache??Guideline of the EFNS headache panel. Eur J Neurol 18:1115–1121. https://doi.org/10.1111/j.1468 PubMedCrossRef

138.

Kennis K, Kernick D, O’Flynn N (2013) Diagnosis and management of headaches in young people and adults: NICE guideline. Br J Gen Pract 63:443–445. https://doi.org/10.3399/bjgp13X670895 PubMedPubMedCentralCrossRef

139.

Becker W, Findlay T, Moga C et al (2015) Guideline for primary care management of headache in adults. Can Fam physician Médecin Fam Can 61:670–679

140.

Grazzi L, Bussone G (2011) What future for treatment of chronic migraine with medication overuse? Neurol Sci 32:S19–S22. https://doi.org/10.1007/s10072 PubMedCrossRef

141.

Katsarava Z, Obermann M (2013) Medication-overuse headache. Curr Opin Neurol 26:276–281. https://doi.org/10.1097/WCO.0b013e328360d596 PubMedCrossRef

142.

Rossi P, Faroni JV, Nappi G (2011) Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 18:396–401. https://doi.org/10.1111/j.1468-1331.2010.03157.x PubMedCrossRef

143.

Rossi P, Faroni JV, Tassorelli C, Nappi G (2013) Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain 14:10. https://doi.org/10.1186/1129-2377-14-10 PubMedPubMedCentralCrossRef

144.

Kristoffersen ES, Straand J, Vetvik KG et al (2016) Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial. J Neurol 263:344–353. https://doi.org/10.1007/s00415-015-7975-1 PubMedCrossRef

145.

Créac’h C, Frappe P, Cancade M et al (2011) In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial. Cephalalgia 31:1189–1198. https://doi.org/10.1177/0333102411412088 PubMedCrossRef

146.

Weatherall MW, Telzerow AJ, Cittadini E et al (2010) Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology 75(12):1098–1103. https://doi.org/10.1212/WNL.0b013e3181f39a11 PubMedCrossRef

147.

Raskin NH (1986) Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 36:995–997. https://doi.org/10.1212/WNL.36.7.995 PubMedCrossRef

148.

Mathew NT (1987) Amelioration of ergotamine withdrawal symptoms with naproxen. Headache J Head Face Pain 27:130–133. https://doi.org/10.1111/j.1526-4610.1987.hed2703130.x CrossRef

149.

Probyn K, Bowers H, Caldwell F et al (2017) Prognostic factors for chronic headache. Neurology 89:291–301. https://doi.org/10.1212/WNL.0000000000004112 PubMedPubMedCentralCrossRef

150.

Nagy AJ, Gandhi S, Bhola R, Goadsby PJ (2011) Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 77(20):1827–1832. https://doi.org/10.1212/WNL.0b013e3182377dbb PubMedCrossRef

151.

Cevoli S, Giannini G, Favoni V et al (2017) Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. J Headache Pain. 18(1):56. https://doi.org/10.1186/s10194-017-0763-9 PubMedPubMedCentralCrossRef

152.

de Goffau MJ, Klaver ARE, Willemsen MG et al (2016) The effectiveness of treatments for patients with medication overuse headache; a systematic review and meta-analysis. J Pain 18:615–627. https://doi.org/10.1016/j.jpain.2016.12.005 PubMedCrossRef

153.

Zebenholzer K, Thamer M, Wöber C (2012) Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study. Clin J Pain 28:284–290. https://doi.org/10.1097/AJP.0b013e3182321d35 PubMedCrossRef

154.

Zeeberg P, Olesen J, Jensen R (2005) Efficacy of multidisciplinary treatment in a tertiary referral headache Centre. Cephalalgia 25:1159–1167. https://doi.org/10.1111/j.1468-2982.2005.00980.x PubMedCrossRef

155.

Pijpers JA, Louter MA, De Bruin ME et al (2016) Detoxification in medication-overuse headache, a retrospective controlled follow-up study: does care by a headache nurse lead to cure? Cephalalgia 36:122–130. https://doi.org/10.1177/0333102415583146 PubMedCrossRef

156.

Tassorelli C, Jensen R, Allena M et al (2014) A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia 34:645–655. https://doi.org/10.1177/0333102414521508 PubMedCrossRef

157.

Rossi P, Jensen R, Nappi G, Allena M (2009) A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 10:407–417. https://doi.org/10.1007/s10194-009-0159-6 PubMedPubMedCentralCrossRef

158.

Chiang C-C, Schwedt TJ, Wang S-J, Dodick DW (2016) Treatment of medication-overuse headache: a systematic review. Cephalalgia 36:371–386. https://doi.org/10.1177/0333102415593088 PubMedCrossRef

159.

Martelletti P (2018) The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine. J Headache Pain 19:2. https://doi.org/10.1186/s10194-017-0830-2 PubMedPubMedCentralCrossRef

160.

Probyn K, Bowers H, Caldwell F et al (2017) Prognostic factors for chronic headache: a systematic review. Neurology 89:291–301PubMedPubMedCentralCrossRef

161.

Hagen K, Jensen R, Bøe MG, Stovner LJ (2010) Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 11:373–377. https://doi.org/10.1007/s10194-010-0221-4 PubMedPubMedCentralCrossRef

162.

Diener HC, Dichgans J, Scholz E et al (1989) Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9–14. https://doi.org/10.1007/BF00314210 PubMedCrossRef

163.

Suhr B, Evers S, Bauer B et al (1999) Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19:44–49PubMedCrossRef

164.

Schnider P, Aull S, Baumgartner C et al (1996) Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 16:481–485PubMedCrossRef

165.

Fritsche G, Eberl A, Katsarava Z et al (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 45:229–235. https://doi.org/10.1159/000052134 PubMedCrossRef

166.

Grazzi L, Andrasik F, D’Amico D et al (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42:483–490. https://doi.org/10.1046/j.1526-4610.2002.02123.x PubMedCrossRef

167.

Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z et al (2007) Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 27:1219–1225. https://doi.org/10.1111/j.1468-2982.2007.01432.x PubMedCrossRef

168.

Bigal ME, Rapoport AM, Sheftell FD et al (2004) Transformed migraine and medication overuse in a tertiary headache Centre--clinical characteristics and treatment outcomes. Cephalalgia an Int J headache 24:483–490. https://doi.org/10.1111/j.1468-2982.2004.00691.x CrossRef

169.

Sances G, Galli F, Anastasi S et al (2010) Medication-overuse headache and personality: a controlled study by means of the MMPI-2: research submission. Headache 50:198–209. https://doi.org/10.1111/j.1526-4610.2009.01593.x PubMedCrossRef

170.

Bøe MG, Salvesen R, Mygland Å (2009) Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. Eur J Neurol 16:705–712. https://doi.org/10.1111/j.1468-1331.2009.02571.x PubMedCrossRef

171.

Bøe MG, Thortveit E, Vatne A, Mygland Å (2017) Chronic headache with medication overuse: long-term prognosis after withdrawal therapy. Cephalalgia 37:1215–1221. https://doi.org/10.1177/0333102416672493 PubMedCrossRef

172.

Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z et al (2016) Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: a prospective cohort study. Cephalalgia 0:1–9. https://doi.org/10.1177/0333102416683918 CrossRef

173.

Evers S, Suhr B, Bauer B et al (1999) A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 246:802–809. https://doi.org/10.1007/s004150050458 PubMedCrossRef

174.

Pini L-A, Cicero A, Sandrini M (2001) Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 21:878–883. https://doi.org/10.1046/j.1468-2982.2001.00288.x PubMedCrossRef

175.

Tribl GG, Schnider P, Wöber C et al (2001) Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 21:691–696PubMedCrossRef

176.

Katsarava Z, Muessig M, Dzagnidze A et al (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25:12–15. https://doi.org/10.1111/j.1468-2982.2004.00789.x PubMedCrossRef

177.

Fontanillas N, Colás R, Muñoz P et al (2010) Long-term evolution of chronic daily headache with medication overuse in the general population. Headache 50:981–988. https://doi.org/10.1111/j.1526-4610.2010.01629.x PubMedCrossRef

178.

Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192–1198. https://doi.org/10.1111/j.1468-2982.2006.01190.x PubMedCrossRef

179.

Katsarava Z, Limmroth V, Finke M et al (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60:1682–1683PubMedCrossRef

180.

Tfelt-Hansen P, Krabbe AÆ (1981) Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1:29–32. https://doi.org/10.1111/j.1468-2982.1981.tb00005.x PubMedCrossRef

181.

Sances G, Ghiotto N, Galli F et al (2010) Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 30:329–336. https://doi.org/10.1111/j.1468-2982.2009.01934.x PubMedCrossRef

182.

Jensen RH, Bendtsen L (2008) Medication overuse headache in Scandinavia. Cephalalgia 28:1237–1239PubMedCrossRef

183.

Serrano D, Lipton RB, Scher AI et al (2017) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain 18:101. https://doi.org/10.1186/s10194-017-0787-1 PubMedPubMedCentralCrossRef

184.

Scher AI, Rizzoli PB, Loder EW (2017) Medication overuse headache an entrenched idea in need of scrutiny. Neurology 89:1296–1304. https://doi.org/10.1212/WNL.0000000000004371 PubMedCrossRef

185.

Solomon M, Nahas SJ, Segal JZ, Young WB (2011) Medication adaptation headache. Cephalalgia 31:515–517. https://doi.org/10.1177/0333102410387678 PubMedCrossRef

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Medication-overuse headache: a widely recognized entity amidst ongoing debate

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Vitamin D deficiency in patients with cluster headache: a preliminary study

Correction to: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study

Myofascial trigger points in migraine and tension-type headache

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study